Opiant Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update

Got To Article
SANTA MONICA, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and ...